Drug Manufacturers-General

1643.HK – Modern Chinese Medicine Group Co Lt

2025-01-07T05:36:20+00:00Categories: Drug Manufacturers-General|Tags: Healthcare, Hong Kong|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China. The company offers vigour and vitality supplement, circulation enhancement, kidney invigoration, menstrual discomfort relief, huoxiang zheng qi, liver-dispersing and stomach regulating, and fever- removing and detoxification pills; cardiotonic enhancement and heart wellness capsules; and liver detox tablets. It offers its products as therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, and respiratory system conditions. It also provides business support, technical, and consulting services. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd. Address: No. 88, Jinwei Road, Chengde, China, 067000

1093.HK – CSPC Pharmaceutical Group Ltd

2025-01-07T04:43:27+00:00Categories: Drug Manufacturers-General|Tags: Healthcare, Hong Kong|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. The company also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, it provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food and glucose products; and healthcare services. The company has a strategic partnership with Pfizer Inc. to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China. Address: No. 226 Huanghe Street, Shijiazhuang, China, 050035

GSK.LSE – GlaxoSmithKline PLC

2025-01-06T15:52:43+00:00Categories: Drug Manufacturers-General|Tags: Healthcare, LSE|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom. Address: 980 Great West Road, Brentford, United Kingdom, TW8 9GS

KOPRAN.BSE – KOPRAN LTD.

2025-01-06T15:09:24+00:00Categories: Drug Manufacturers-General|Tags: Healthcare, India|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritionals; urinary health; weight management; immunity; skin, hair, and nails; liver and digestion; fertility, pregnancy, and postpartum; blood sugar management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidants; bones, joints, and muscles; and eye health. The company markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia. Address: Bath Road, Kirrawee, NSW, Australia, 2232

H02.SG – HAW PAR CORP LTD

2025-01-06T13:41:39+00:00Categories: Drug Manufacturers-General|Tags: Healthcare, Singapore|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities primarily in the form of oceanariums. Further, the company is involved in the property development services; letting out of office spaces; and management support services. Haw Par Corporation Limited was incorporated in 1969 and is based in Singapore. Address: No. 03-03 Haw Par Technocentre, Singapore, Singapore, 149598

GLAXO.BSE – GLAXOSMITHKLINE PHARMACEUTICALS LTD.

2025-01-06T12:49:48+00:00Categories: Drug Manufacturers-General|Tags: Healthcare, India|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Minerals 260 Limited engages in the exploration and evaluation of mineral resources in Australia. The company explores for gold, platinum, palladium, nickel, copper, lithium, and rare earths elements, as well as precious and battery-related metals. It holds 100% interests in the Aston project that includes 14 granted contiguous tenements covering an area of 1,709 square kilometers and four pending tenements covering an area of 84 square kilometers located in the Gascoyne Province of Western Australia; and the Moora project covering an area of 370 square kilometers located in Julimar Mineral Province, southwest Western Australia. The company also holds a 100% interest in the Dingo Rocks project located in south-eastern Western Australia. The company was incorporated in 2021 and is based in West Perth, Australia. Address: 1292 Hay Street, West Perth, WA, Australia, 6005

600771.SHG – GuangYuYuan Chinese Herbal Medicine Co Ltd

2025-01-06T12:01:21+00:00Categories: Drug Manufacturers-General|Tags: China, Healthcare|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

GuangYuYuan Chinese Herbal Medicine Co., Ltd. manufactures and sells Chinese medicinal products. The company offers traditional and fine Chinese medicines, as well as health wines. It provides its products in the form of pills, powders, tablets, hard capsules, granules, oral liquids, decoctions, and wines. The company was formerly known as Topsun Science And Technology Co Ltd. and changed its name to GuangYuYuan Chinese Herbal Medicine Co., Ltd. in July 2013. GuangYuYuan Chinese Herbal Medicine Co., Ltd. was founded in 1541 and is based in Xi'an, China. Address: Building A, 6th Floor, Xi'an, China, 710065

600713.SHG – NanJing Pharmaceutical Co Ltd

2025-01-06T11:55:04+00:00Categories: Drug Manufacturers-General|Tags: China, Healthcare|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

NanJing Pharmaceutical Company Limited engages in the pharmaceutical wholesale and retail businesses in China. It also operates an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China. Address: Building A, Nanjing, China, 210012

600671.SHG – Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

2025-01-06T11:51:18+00:00Categories: Drug Manufacturers-General|Tags: China, Healthcare|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces and sells medicines and related health care products, including tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, pills, soft capsules, tablets, granules, and other health foods. It is also involved in the sale of menthol and peppermint oil raw materials, Chinese medicine formulas, Chinese medicine pieces, fresh herbs, etc.; and provision of professional medical services, such as valet decoction and distribution, as well as Chinese medicine diagnosis and treatment services. In addition, the company engages in the software development, remote health management, commercial complex management, food, Internet information businesses, etc. The company was founded in 1958 and is headquartered in Hangzhou, China. Address: Block B, Zhongke National Technology Transfer Center, Hangzhou, China

600666.SHG – Aurora Optoelectronics Co Ltd

2025-01-06T11:50:57+00:00Categories: Drug Manufacturers-General|Tags: China, Healthcare|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Aurora Optoelectronics Co.,Ltd. engages in the research and development, production, and sale of sapphire crystal materials in China. It also offers special equipment; computing services; investment management; scientific research and technical services; and engages in the computer power leasing. The company was incorporated in 2006 and is headquartered in Harbin, China. Address: Building 2, No. 288 Zhigu Street, Harbin, China, 150000